Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT00897169 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects

Start date: June 2009
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe and Japan. The aim of this clinical trial is to investigate the possible difference in the development of type 2 diabetes in a Japanese and a Caucasian population. Healthy subjects, subjects with impaired glucose tolerance, as well as subjects with type 2 diabetes will be included in the trial. The development of type 2 diabetes across the cohort will be investigated with regard to insulin sensitivity and B-cell capacity.

NCT ID: NCT00895921 Completed - Diabetes Clinical Trials

Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

Start date: November 2008
Phase: Phase 4
Study type: Interventional

This study will examine the effects of two different antipsychotic medications on control of blood sugar in people who are at risk of diabetes but mentally healthy.

NCT ID: NCT00895427 Completed - Diabetes Clinical Trials

A Study Comparing Skin Fluorescence to Coronary Artery Calcification

CACS
Start date: February 2009
Phase: N/A
Study type: Observational

This study examines the relationship between the SCOUT DM device and coronary artery calcification as determined by rapid computed tomography in patients at risk for coronary heart disease.

NCT ID: NCT00894270 Completed - Diabetes Mellitus Clinical Trials

Comparison of Vehicle Delivery Depth Using the NovoFine® 5 mm Needle With or Without a Skin Fold and Inserted at Either 45 or 90 Degrees

Start date: November 2008
Phase: Phase 4
Study type: Interventional

Children and adolescents with type 1 diabetes mellitus are required to inject insulin daily. The injection technique should reliably deposit insulin into subcutaneous fat while minimizing inadvertent delivery into either the skin or the underlying muscle, both of which are associated with suboptimal outcomes. The use of shorter, thinner needles reduces the incidence of intramuscular delivery and is associated with reduced discomfort, but increases the risks of both shallow (intradermal) delivery and of loss of insulin through backflow to the skin surface. In the current study, 240 subjects (children and adults) will receive multiple injections of small volumes of sterile air in the thigh and abdomen using 5 mm Novofine® needles, to simulate insulin injections performed at the two sites using various injection techniques (perpendicular or angled needle, with or without skin fold). Ultrasound visualisation of the injected air will allow determination of the incidence of intradermal or intramuscular delivery using the various delivery methods in the trial. In addition, adult subjects will receive injections of a liquid test medium in order to determine the incidence and extent of backflow. Qualitative data on perceived discomfort and information on body composition will also be collected. This investigation will form the basis for recommendations regarding preferred injection technique where 5 mm needles are used.

NCT ID: NCT00892151 Completed - Diabetes Mellitus Clinical Trials

Evaluation of GLUCOFACTS® Deluxe Diabetes Management System

Start date: April 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate a Diabetes management program in the hands of potential users, both health care professionals and lay persons.

NCT ID: NCT00889486 Completed - Diabetes Mellitus Clinical Trials

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Start date: April 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of TZP-102 on gastric emptying rate, gastroparesis symptoms and health-related quality of life in diabetic patients with gastroparesis.

NCT ID: NCT00888732 Completed - Clinical trials for Diabetes Mellitus, Type 1

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The hypothesis is that an optimal formulation of fast acting and intermediary acting insulin analogues will improve post prandial glycaemic control in patients with type 1 diabetes

NCT ID: NCT00888628 Completed - Clinical trials for Diabetes Mellitus, Type I

Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

Start date: May 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to learn if islet transplantation is an effective treatment for Type 1 diabetes in people who have had a kidney transplant. The primary objectives of the study are: - To set up islet transplantation in patients who have had a kidney transplant and who are using an immunosuppressive regimen that works The Secondary objective of the study is: - To find out if successful islet transplantation leads to improved metabolic control and reduced renal complication from diabetes

NCT ID: NCT00887874 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan

DiabCare Asia
Start date: May 2009
Phase: N/A
Study type: Observational

This study is conducted in Asia. The aim of this observational study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in Asia.

NCT ID: NCT00887094 Completed - Clinical trials for Diabetes Mellitus, Type 2

Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes

CGMSexercise
Start date: June 2009
Phase: N/A
Study type: Interventional

Many studies were already performed showing beneficial cardiovascular and metabolic effects of physical training for type 2 diabetic patients. However, glucose profile during and immediately after a short period of aerobic and/or resistance training was not studied yet. Continuous glucose monitoring system (CGMS) has now been added to the repertoire of technological devices useful in the management of patients with diabetes. Such monitoring enables clinicians to detect occult hypoglycemia and hyperglycemia not otherwise discernable with intermittent testing of blood glucose. The main aim of the present study is to investigate continuous blood glucose profile (using CGMS) over 72h, beginning 24h before and ending 24h after a single bout of aerobic or aerobic/resistance physical training in type 2 diabetic patients.